Covidien president & CEO AdvaMed board chairman Jose Almeida details his focus for his 2-year tenure as the chairman of the board for medtech lobbying group AdvaMed.
Incoming AdvaMed chairman Jose Almeida has an international outlook, planning to focus his 2-year leadership tenure on several goals that aim to reconcile initiatives in the U.S. with efforts overseas.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1h4v0cV
Cap comentari:
Publica un comentari a l'entrada